KM
Kalos Management Portfolio holdings
AUM
$46.6M
This Quarter Return
-13.2%
1 Year Return
+11.52%
3 Year Return
+47.83%
5 Year Return
+70.92%
10 Year Return
–
AUM
$74.4M
AUM Growth
+$74.4M
(-49%)
Cap. Flow
-$60.5M
Cap. Flow
% of AUM
-81.34%
Top 10 Holdings %
Top 10 Hldgs %
34.2%
Holding
182
New
5
Increased
32
Reduced
82
Closed
44
Top Buys
| 1 |
Vanguard Value ETF
VTV
|
$618K |
| 2 |
Schwab US Large-Cap Value ETF
SCHV
|
$612K |
| 3 |
Alphabet (Google) Class C
GOOG
|
$501K |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
$375K |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
$286K |
Top Sells
| 1 |
Phillips Edison & Co
PECO
|
$8.62M |
| 2 |
FS KKR Capital
FSK
|
$4.27M |
| 3 |
DMA
Destra Multi-Alternative Fund
DMA
|
$1.95M |
| 4 |
CION Investment
CION
|
$1.59M |
| 5 |
BRSP
BrightSpire Capital
BRSP
|
$1.1M |
Sector Composition
| 1 | Real Estate | 7.55% |
| 2 | Technology | 7.1% |
| 3 | Financials | 6.26% |
| 4 | Healthcare | 3.77% |
| 5 | Consumer Discretionary | 3.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
National Health Investors
NHI
$3.68B
| $292K | 0.39% |
4,756
-69
| -1% | -$4.24K |
|
77
Mastercard
MA
$536B
| $290K | 0.39% |
914
-218
| -19% | -$69.2K |
|
78
American Tower
AMT
$91.9B
| $287K | 0.39% |
1,114
-19
| -2% | -$4.9K |
|
79
AT&T
T
$208B
| $282K | 0.38% |
13,734
-5,071
| -27% | -$229K |
|
80
Eli Lilly
LLY
$661B
| $279K | 0.37% |
+862
| New | +$279K |
|
81
Ares Capital
ARCC
$15.7B
| $277K | 0.37% |
15,361
+1,130
| +8% | +$20.4K |
|
82
Fidelity Low Volatility Factor ETF
FDLO
$1.3B
| $277K | 0.37% |
6,022
| – | – |
|
83
Nike
NKE
$110B
| $270K | 0.36% |
2,643
+7
| +0.3% | +$715 |
|
84
Zoetis
ZTS
$67.6B
| $266K | 0.36% |
1,529
| – | – |
|
85
Ventas
VTR
$30.7B
| $265K | 0.36% |
5,176
-611
| -11% | -$31.3K |
|
86
Schwab US Large-Cap Growth ETF
SCHG
$48B
| $264K | 0.35% |
4,236
-436
| -9% | -$27.2K |
|
87
Canadian National Railway
CNI
$60.3B
| $263K | 0.35% |
2,332
| – | – |
|
88
CDW
CDW
$21.4B
| $260K | 0.35% |
1,659
| – | – |
|
89
Visa
V
$681B
| $260K | 0.35% |
1,293
-192
| -13% | -$38.6K |
|
90
S&P Global
SPGI
$165B
| $258K | 0.35% |
754
-7
| -0.9% | -$2.4K |
|
91
Tesla
TSLA
$1.08T
| $258K | 0.35% |
330
| – | – |
|
92
Accenture
ACN
$158B
| $256K | 0.34% |
915
| – | – |
|
93
BioCryst Pharmaceuticals
BCRX
$1.74B
| $256K | 0.34% |
23,900
+450
| +2% | +$4.82K |
|
94
Sherwin-Williams
SHW
$90.5B
| $254K | 0.34% |
1,084
+22
| +2% | +$5.16K |
|
95
Coca-Cola
KO
$297B
| $252K | 0.34% |
3,959
-3,768
| -49% | -$240K |
|
96
CoStar Group
CSGP
$37.2B
| $250K | 0.34% |
4,000
| – | – |
|
97
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $248K | 0.33% |
6,083
-1,418
| -19% | -$57.8K |
|
98
Pinnacle Financial Partners
PNFP
$7.56B
| $246K | 0.33% |
3,339
| – | – |
|
99
Acadia Pharmaceuticals
ACAD
$4.34B
| $244K | 0.33% |
17,075
-1,150
| -6% | -$16.4K |
|
100
Origin Materials
ORGN
$82.2M
| $243K | 0.33% |
48,013
-1,100
| -2% | -$5.57K |
|